DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews

被引：0
|
作者：
Juan Ling
Long Ge
Ding-hua Zhang
Yong-feng Wang
Zhuo-lin Xie
Jin-hui Tian
Xiao-hui Xiao
Ke-hu Yang
机构：
[1] Lanzhou University,School of Basic Medical Sciences, Evidence
[2] Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province,Based Medicine Center
[3] Lanzhou University,Chinese GRADE Center
[4] WHO Collaborating Center for Guideline Implementation and Knowledge Translation,School of Basic Medical Sciences
[5] The First Clinical Medical College of Lanzhou University,Department of Endocrinology
[6] Gansu University of Traditional Chinese Medicine,undefined
[7] Gansu University of Traditional Chinese Medicine,undefined
[8] Gansu Province Hospital of Traditional Chinese Medicine,undefined
[9] Gansu Provincial People’s Hospital,undefined
来源：
Acta Diabetologica | 2019年 / 56卷
关键词：
Dipeptidyl peptidase 4 inhibitors; Systematic reviews; Type 2 diabetes mellitus; AMSTAR; GRADE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 27
页数：20
相关论文
共 50 条
  • [31] Impact of DPP-4 Inhibitors on Interleukin Levels in Type 2 Diabetes Mellitus
    Feng, Yiduo
    Shang, Beibei
    Yang, Yu
    Zhang, Donglei
    Liu, Changbin
    Qin, Zheng
    Zhou, Yilun
    Meng, Jie
    Liu, Xin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [32] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Lerch, C. L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [33] DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Sugimoto, Toshitsugu
    MEDICAL SCIENCE MONITOR, 2014, 20 : 1662 - 1667
  • [34] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    不详
    JOURNAL OF DIABETES, 2009, 1 (01) : 6 - 7
  • [35] Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
    Crepaldi, G.
    Carruba, M.
    Comaschi, M.
    Del Prato, S.
    Frajese, G.
    Paolisso, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (07) : 610 - 614
  • [36] The influence of DPP-4 inhibitors on fat metabolism in type 2 diabetes patients
    Ametov, A. S.
    Gusenbekova, D. G.
    DIABETOLOGIA, 2014, 57 : S378 - S378
  • [37] Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
    G. Crepaldi
    M. Carruba
    M. Comaschi
    S. Del Prato
    G. Frajese
    G. Paolisso
    Journal of Endocrinological Investigation, 2007, 30 : 610 - 614
  • [38] The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
    Choe, Eun Yeong
    Cho, Yongin
    Choi, Younjeong
    Yun, Yujung
    Wang, Hye Jin
    Kwon, Obin
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    DIABETES & METABOLISM JOURNAL, 2014, 38 (03) : 211 - 219
  • [39] DPP-4 inhibitor approved for the treatment of type 2 diabetes mellitus
    不详
    FORMULARY, 2009, 44 (09) : 261 - 261
  • [40] Sitagliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Johnson, Kathryn M. S.
    Schurr, Kathleen
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 81 - 92
12345